$Tesla (TSLA.US)$ First look at 315

$GameStop (GME.US)$ just a bunch of new shortie trolls beatin’ down wishful thinkers, bag holders, and apes.

$Crown Electrokinetics (CRKN.US)$  Old Windows Are Costing Americans $45 Billion Per Year in Energy Waste.  Video -  https://vimeo.com/693652356

But the company still burns through $460m annually while reporting declining earnings YoY.
So if you think -12% in one day is bad, just remember, GME’s market cap is still at 10.6B. 4B cash on hand taken into consideration still won’t even merit half its current valuation.
Good luck to all opting to dig themselves deeper into sunk cost. Rocket will come any day now!! 🚀🚀
$GameStop (GME.US)$

In the fiscal fourth quarter of 2023, $Faraday Future Intelligent Electric Inc. (FFIE.US)$'s revenue decreased by 58% to $233,000, 100% coming from auto sales. Cost of goods sold increased by 23% to $20 million, and net profit dropped by 7% to -$84 million. Faraday's after-hours stock price fell by 27.44% to $0.85 at 11:05 PM EDT on May 28. This month, the company launched the ultimate AI TechLuxury FF 912.0 Futurist Alliance, p...

$Greenwave Technology Solutions (GWAV.US)$  getting ready to hit a new high next week start of an up trend/ revarsal watch for the conecting new swing highs you can either hold for a week or trade the highs and lows either way with everything giing on i dont see this going any lower 🙏👍

$Tesla (TSLA.US)$ $BYD COMPANY (01211.HK)$ $NIO Inc (NIO.US)$ $XPeng (XPEV.US)$ The article reported that Elon Musk acknowledged Nvidia CEO  Jensen Huang‘s recent comments about Tesla being a leader in autonomous vehicles. Huang stated that every car would eventually need autonomous capabilities. Musk posted, “Thanks Jensen!” in response to a post by Sawyer Merritt, which quoted Huang’s recent interview.
Huang had said, “Tesla is...

$Nanoviricides (NNVC.US)$
NEWS
NanoViricides Bolsters Partnership Efforts - Engages Aagami Inc
NanoViricides has engaged Aagami Inc. to seek licensing and partnering opportunities for its key asset, NV-387, and platform technology in India and Japan. NV-387, a broad-spectrum antiviral nanomedicine, has completed Phase I clinical trials in healthy subjects with no adverse effects reported. It is now ready for Phase II trials.
NV-387, designed to mimic host-side virus-binding features, targets a wi...

Morning mooers! It is Wednesday May 22, the market is cautiously flat, awaiting Nvidia earnings after market closes.
My name is Kevin Travers, and here are the stories moving on Wall Street Today:
$Target (TGT.US)$'s fiscal first-quarter earnings missed Wall Street's estimates by 3C, and were 1% below last year's $2.05. Shares in the firm fell 8% in early trading, the lowest decline on the S&P 500.
The largest gainer on the S&P 500...